The BCW Index fell 1.9 percent for the five-day trading period ended Tuesday, mirroring a drop in the broader stock market. For the tracking period, the Dow Jones Industrial Average fell 1.5 percent, the Nasdaq declined 1.6 percent, and the Nasdaq Biotech Index dropped 2.6 percent.
 
Fourteen of the 15 companies in the Index lost value, with Qiagen and Bruker BioSciences both falling 4 percent to lead decliners for the week. Stratagene was the only firm to gain ground, closing up 2.6 percent for the week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.